LONDON: Astrazeneca said on Thursday that he intended to seek US authorization for the Covid-19 vaccine in the second half of this year, offering a new schedule for many pending applications.
Anglo-Sweden drug makers announced a schedule for releasing the second quarter financial results, which showed that the company and sub-license sub-holders sent more than 700 million vaccine doses to more than 170 countries in the first half of this year.
It includes 80 million doses that go to Covax initiative for low and medium-income countries.
News about US archiving is being watched tightly, because the period of time has slipped.
When AstraZeneca released data from US courts from vaccines on March 22, company officials said they were expected to seek authorization from food and drugs in the first half of April.
In April, the company said it was expected to submit US applications in “next week.
” EU Health Organization and World Health have used AstraZeneca vaccine.
Astrazeneca reported the first semester revenue of $ 1.17 billion from the delivery of 319 million doses of vaccine Directly by the company.
Astrazeneca has promised to send a vaccine based on a non-profit during the pandemic taking place.
Although there are complaints from the European Union about the supply of vaccines, block 27 countries receive more direct doses of astrazeneca than other entities in the first half of this year.
The company sent 97 million doses to the EU, while Brazil received 65 million and England 52 million, said Astran, an alliance that secured a vaccine for low-income countries, received 49 million doses, and 57 million other doses went to another country.
License sub-holders, Including the Institute of India, supply millions of more do SIS, pushed de global liver to more than 700 million doses.
This vaccine was developed by the University of Oxford researchers, who licensed the technology to Astrazeneca in an effort to utilize the company’s global production and distribution capacity.
AstraZeneca, in turn, authorizes other companies to produce shots around the world.
AstraZeneca to find Covid vaccine approval in half the 2nd
